Merus (MRUS) News Today $43.22 +0.79 (+1.86%) Closing price 04:00 PM EasternExtended Trading$43.25 +0.03 (+0.07%) As of 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Fmr LLC Has $290.13 Million Holdings in Merus (NASDAQ:MRUS)Fmr LLC lifted its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 0.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,899,521 shares of the biotechnology company's stock after buying an additApril 13 at 5:25 AM | marketbeat.comMerus (NASDAQ:MRUS) Sets New 12-Month Low - Should You Sell?Merus (NASDAQ:MRUS) Reaches New 52-Week Low - Here's WhyApril 12 at 5:16 AM | marketbeat.comRaymond James Financial Inc. Invests $347,000 in Merus (NASDAQ:MRUS)Raymond James Financial Inc. purchased a new position in shares of Merus (NASDAQ:MRUS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,231 shares of the biotechnology company's stock, valued at approxiApril 12 at 3:07 AM | marketbeat.comMerus' (MRUS) "Buy" Rating Reiterated at Needham & Company LLCApril 12 at 2:35 AM | americanbankingnews.comMerus (NASDAQ:MRUS) Earns Buy Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $83.00 target price on shares of Merus in a research report on Wednesday.April 11, 2025 | marketbeat.comCenterBook Partners LP Buys 124,174 Shares of Merus (NASDAQ:MRUS)CenterBook Partners LP raised its stake in Merus (NASDAQ:MRUS - Free Report) by 664.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 142,875 shares of the biotechnology company's stock after acquiriApril 11, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Receives $85.31 Consensus Target Price from AnalystsApril 10, 2025 | americanbankingnews.comMerus (NASDAQ:MRUS) Shares Sold by ADAR1 Capital Management LLCADAR1 Capital Management LLC lowered its position in shares of Merus (NASDAQ:MRUS - Free Report) by 46.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,460 shares of the biotechnology company's stock after seApril 9, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Sold by Federated Hermes Inc.Federated Hermes Inc. lessened its holdings in Merus (NASDAQ:MRUS - Free Report) by 20.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,593,375 shares of the biotechnology company's stock after selling 413,425 shareApril 9, 2025 | marketbeat.comSpringhill Fund Asset Management HK Co Ltd Invests $3.52 Million in Merus (NASDAQ:MRUS)Springhill Fund Asset Management HK Co Ltd bought a new position in Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 83,800 shares of the biotechnology company's stock, valued at appApril 8, 2025 | marketbeat.comAlliancebernstein L.P. Increases Holdings in Merus (NASDAQ:MRUS)Alliancebernstein L.P. boosted its position in Merus (NASDAQ:MRUS - Free Report) by 9.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 796,957 shares of the biotechnology company'sApril 8, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Receives Consensus Recommendation of "Buy" from AnalystsMerus (NASDAQ:MRUS - Get Free Report) has earned an average recommendation of "Buy" from the sixteen ratings firms that are currently covering the company, MarketBeat.com reports. Fourteen analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation toApril 8, 2025 | marketbeat.comMerus: Riding The Bispecific Wave In OncologyApril 7, 2025 | seekingalpha.comTrexquant Investment LP Sells 9,711 Shares of Merus (NASDAQ:MRUS)Trexquant Investment LP trimmed its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 8.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 100,733 shares of the biotechnology company's stock after selling 9,711 shApril 7, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Reaches New 1-Year Low - Should You Sell?Merus (NASDAQ:MRUS) Sets New 12-Month Low - Here's WhyApril 6, 2025 | marketbeat.comKLP Kapitalforvaltning AS Purchases New Holdings in Merus (NASDAQ:MRUS)KLP Kapitalforvaltning AS acquired a new position in shares of Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 10,300 shares of the biotechnology company's stock, valued at approximately $43April 6, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Sold by Franklin Resources Inc.Franklin Resources Inc. reduced its position in Merus (NASDAQ:MRUS - Free Report) by 12.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,984,538 shares of the biotechnology company's stock after selling 271,966 shares durinApril 5, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Stock Position Lifted by Wellington Management Group LLPWellington Management Group LLP raised its stake in Merus (NASDAQ:MRUS - Free Report) by 21.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,497,653 shares of the biotechnology company's stock after buying an additional 610,139 sharesApril 5, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Trading 7.5% Higher - Here's What HappenedMerus (NASDAQ:MRUS) Trading Up 7.5% - Should You Buy?April 4, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Down 7.6% - Time to Sell?Merus (NASDAQ:MRUS) Stock Price Down 7.6% - Should You Sell?April 1, 2025 | marketbeat.comMerus to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare ConferenceApril 1, 2025 | globenewswire.comPictet Asset Management Holding SA Increases Stock Position in Merus (NASDAQ:MRUS)Pictet Asset Management Holding SA increased its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 1.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,031,827 shares of the biotechnology company's stock after purchasApril 1, 2025 | marketbeat.comMerus' (MRUS) Buy Rating Reiterated at GuggenheimGuggenheim reissued a "buy" rating and set a $109.00 price objective on shares of Merus in a research note on Friday.March 29, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Bought by BIT Capital GmbHBIT Capital GmbH increased its position in Merus (NASDAQ:MRUS - Free Report) by 167.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,402 shares of the biotechnology company's stock after acquiriMarch 28, 2025 | marketbeat.comMerus, Urban Sites unveil $26M Kenton County apartment projectMarch 27, 2025 | bizjournals.comSwiss National Bank Purchases 8,300 Shares of Merus (NASDAQ:MRUS)Swiss National Bank increased its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 9.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 93,954 shares of the biotechnology company's stock afterMarch 26, 2025 | marketbeat.comMerus (MRUS) Gets a Buy from CitiMarch 22, 2025 | markets.businessinsider.comBuy Rating on Merus: Promising Potential of Petosemtamab in Combination with PD-1 Therapy for Head and Neck CancerMarch 21, 2025 | tipranks.comMerus (NASDAQ:MRUS) Earns "Buy" Rating from GuggenheimGuggenheim reissued a "buy" rating and issued a $109.00 price target on shares of Merus in a research report on Tuesday.March 19, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Gap Up - Still a Buy?Merus (NASDAQ:MRUS) Shares Gap Up - Should You Buy?March 18, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Given Average Recommendation of "Buy" by BrokeragesShares of Merus (NASDAQ:MRUS - Get Free Report) have received an average recommendation of "Buy" from the sixteen research firms that are currently covering the company, Marketbeat reports. Fourteen investment analysts have rated the stock with a buy rating and two have issued a strong buy ratingMarch 13, 2025 | marketbeat.comBank of America Has Lowered Expectations for Merus (NASDAQ:MRUS) Stock PriceBank of America reduced their price target on shares of Merus from $73.00 to $70.00 and set a "buy" rating for the company in a research note on Monday.March 11, 2025 | marketbeat.comBank of America Securities Remains a Buy on Merus (MRUS)March 10, 2025 | markets.businessinsider.comMerus (NASDAQ:MRUS) Short Interest UpdateMerus (NASDAQ:MRUS - Get Free Report) was the target of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 6,640,000 shares, a decline of 13.5% from the January 31st total of 7,680,000 shares. Based on an average daily trading volume, of 629,600 shares, the short-interest ratio is currently 10.5 days.March 7, 2025 | marketbeat.comStifel Nicolaus Sticks to Its Buy Rating for Merus (MRUS)March 6, 2025 | markets.businessinsider.comHC Wainwright Reaffirms Buy Rating for Merus (NASDAQ:MRUS)HC Wainwright reaffirmed a "buy" rating and issued a $85.00 price target on shares of Merus in a research note on Monday.March 3, 2025 | marketbeat.comWilliam Blair Estimates Merus' FY2028 Earnings (NASDAQ:MRUS)Merus (NASDAQ:MRUS - Free Report) - Stock analysts at William Blair issued their FY2028 earnings estimates for Merus in a research note issued to investors on Friday, February 28th. William Blair analyst M. Phipps forecasts that the biotechnology company will post earnings of ($3.58) per share foMarch 3, 2025 | marketbeat.comMerus' (MRUS) Outperform Rating Reaffirmed at William BlairWilliam Blair reissued an "outperform" rating on shares of Merus in a research note on Friday.March 1, 2025 | marketbeat.comTruist Financial Sticks to Their Buy Rating for Merus (MRUS)March 1, 2025 | markets.businessinsider.comAnalyst Forecasts Just Became More Bearish On Merus N.V. (NASDAQ:MRUS)March 1, 2025 | finance.yahoo.comMerus (NASDAQ:MRUS) Given New $83.00 Price Target at Needham & Company LLCNeedham & Company LLC reduced their price objective on shares of Merus from $85.00 to $83.00 and set a "buy" rating on the stock in a research note on Friday.March 1, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Posts Quarterly Earnings Results, Beats Estimates By $0.48 EPSMerus (NASDAQ:MRUS - Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.41) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.89) by $0.48. Merus had a negative return on equity of 38.89% and a negative net margin of 680.61%.February 28, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Merus (MRUS), Krystal Biotech (KRYS) and Treace Medical Concepts (TMCI)February 28, 2025 | markets.businessinsider.comMerus (MRUS) Receives a Buy from Stifel NicolausFebruary 28, 2025 | markets.businessinsider.comMerus’s Strategic Advancements and Clinical Progress Justify Buy RatingFebruary 28, 2025 | tipranks.comMerus’s Promising Clinical Advances and Breakthrough Therapy Designation Justify Buy RatingFebruary 28, 2025 | tipranks.comMerus’s Promising Clinical Developments and Regulatory Progress Justify Buy RatingFebruary 27, 2025 | tipranks.comMerus NV (MRUS) Announces Key Developments in Oncology Trials and Financial ResultsFebruary 27, 2025 | gurufocus.comMerus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business UpdateFebruary 27, 2025 | globenewswire.comMerus to Present at Upcoming Investor ConferencesFebruary 25, 2025 | globenewswire.com Remove Ads Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address MRUS Media Mentions By Week MRUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRUS News Sentiment▼1.160.80▲Average Medical News Sentiment MRUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRUS Articles This Week▼115▲MRUS Articles Average Week Remove Ads Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Dr. Reddy's Laboratories News Today Moderna News Today Ascendis Pharma A/S News Today Qiagen News Today Viatris News Today Roivant Sciences News Today Lantheus News Today Revolution Medicines News Today BridgeBio Pharma News Today TG Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRUS) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merus Please log in to your account or sign up in order to add this asset to your watchlist. Share Merus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
